CompaniesByCap
RCUS
Arcus Biosciences Inc. (RCUS)
NYSE · Healthcare

Arcus Biosciences Inc. Income Statement 2017–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Revenues
Revenue33.0M51.0M37.0M38.0M383.0M78.0M15.0M8.4M1.4M
Gross Profit
Profitability
Operating Income-386.0M-330.0M-340.0M-280.0M54.0M-124.0M-88.7M-54.9M-53.4M
EBITDA-376.0M-320.0M-332.0M-274.0M58.0M-121.0M-85.1M-51.2M-50.8M
Net Income-353.0M-283.0M-307.0M-267.0M53.0M-123.0M-84.7M-49.6M-53.1M
Per Share Data
EPS (diluted)$-3.29$-3.14$-4.15$-3.71$0.71$-2.24$-1.93
Shares Outstanding (dil.)107M90M74M72M74M55M44M45M4M

Arcus Biosciences Inc. Income Statement — FAQ

Arcus Biosciences Inc. (RCUS) income statement over the last 9 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see RCUS's income statement history?

The chart and table above show Arcus Biosciences Inc.'s income statement by year and by quarter, including the growth rate.